Chronic helminth infection does not impair immune response to malaria transmission blocking vaccine Pfs230D1-EPA/Alhydrogel® in mice

INTRODUCTION: Malaria transmission blocking vaccines (TBV) are innovative approaches that aim to induce immunity in humans against Plasmodium during mosquito stage, neutralizing the capacity of the infected vectors to transmit malaria. Pfs230D1-EPA/Alhydrogel®, a promising protein-protein conjugate...

Descripción completa

Detalles Bibliográficos
Autores principales: Coelho, Camila H., Gazzinelli-Guimaraes, Pedro Henrique, Howard, Jennifer, Barnafo, Emma, Alani, Nada A.H., Muratova, Olga, McCormack, Ashley, Kelnhofer, Emily, Urban, Joseph F., Narum, David L., Anderson, Charles, Langhorne, Jean, Nutman, Thomas B., Duffy, Patrick E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Science 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6382667/
https://www.ncbi.nlm.nih.gov/pubmed/30685251
http://dx.doi.org/10.1016/j.vaccine.2019.01.027

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6382667/
https://www.ncbi.nlm.nih.gov/pubmed/30685251
http://dx.doi.org/10.1016/j.vaccine.2019.01.027

Ejemplares similares